- Advanced search
- Immuno Portal
- Malaria Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|International Nonproprietary Names|
|SB 223412 | SB-223,412 | SB-223412 | SB223412|
|Talnetant (SB-223412) is an orally active, selective neurokinin-3 (NK3) receptor antagonist that was developed as a potential anti-schizophrenia drug [2-4,6,8].
There is some ambiguity in the stereochemical representation of talnetant as shown on other databases. The structure shown above is the same as the INN-assigned structure and shows the (S)-isomer of the compound.
|CAS Registry No.||174636-32-9 (source: Scifinder)|
|GtoPdb PubChem SID||135650992|
|Search Google for chemical match using the InChIKey||BIAVGWDGIJKWRM-FQEVSTJZSA-N|
|Search Google for chemicals with the same backbone||BIAVGWDGIJKWRM|
|Search PubMed clinical trials||talnetant|
|Search PubMed titles||talnetant|
|Search PubMed titles/abstracts||talnetant|
|Search UniChem for chemical match using the InChIKey||BIAVGWDGIJKWRM-FQEVSTJZSA-N|
|Search UniChem for chemicals with the same backbone||BIAVGWDGIJKWRM|
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Cat. No. 4672